Medicare Participation Announcement for CY 2026: Decide by December 31
Please see this important announcement for CY 2026 regarding Medicare participation.
Treatment of abnormal uterine bleeding with intrauterine device (hormone-eluting)
Chronic abnormal uterine bleeding (AUB) describes irregularities in the menstrual cycle involving frequency, regularity...
Florida and U.S. Virgin Islands Part B POE-AG minutes - November 13, 2025
Review these meeting minutes from the Part B POE AG meeting.
Florida and U.S. Virgin Islands Part A POE-AG minutes - November 11, 2025
View this review of the November JN Part A POE AG meeting.
Cognitive assessment and care plan services
If your patient shows signs of cognitive impairment during a routine visit, Medicare covers a separate visit to more thoroughly...
New high-cost cell-based gene therapy drug Encelto approved for use in the ambulatory surgical center (ASC) setting
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center...
MLN Connects Special Edition for November 7, 2025
View this special edition update on processing of telehealth and acute hospital care at home claims.
Appeal status requests must be obtained through SPOT
To enhance efficiency and ensure the secure handling of appeal information, all providers will be required to use SPOT to check...
MLN Connects Special Edition for November 3, 2025
View this special edition on recent CMS actions.